lacosamide
Generic: lacosamide
Labeler: american health packagingDrug Facts
Product Profile
Brand Name
lacosamide
Generic Name
lacosamide
Labeler
american health packaging
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
lacosamide 50 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
60687-676
Product ID
60687-676_4c5d9cc4-2e98-ae84-e063-6394a90af1d6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214695
DEA Schedule
cv
Listing Expiration
2027-12-31
Marketing Start
2022-06-01
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
60687676
Hyphenated Format
60687-676
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lacosamide (source: ndc)
Generic Name
lacosamide (source: ndc)
Application Number
ANDA214695 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
Packaging
- 60 BLISTER PACK in 1 CARTON (60687-676-57) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-676-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4c5d9cc4-2e98-ae84-e063-6394a90af1d6", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809996", "810000"], "spl_set_id": ["19060029-c158-4a37-9261-cfe3b2b5b1e3"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "60 BLISTER PACK in 1 CARTON (60687-676-57) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-676-11)", "package_ndc": "60687-676-57", "marketing_start_date": "20220601"}], "brand_name": "Lacosamide", "product_id": "60687-676_4c5d9cc4-2e98-ae84-e063-6394a90af1d6", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "60687-676", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "50 mg/1"}], "application_number": "ANDA214695", "marketing_category": "ANDA", "marketing_start_date": "20220601", "listing_expiration_date": "20271231"}